| scholarly article | Q13442814 |
| P50 | author | Willem de Vos | Q8003634 |
| Jarkko Salojärvi | Q43175492 | ||
| Anne Salonen | Q45931194 | ||
| Jonna Jalanka | Q57013504 | ||
| Airi Palva | Q114314943 | ||
| Leo Lahti | Q42633248 | ||
| P2093 | author name string | Matej Orešič | |
| Riina A Kekkonen | |||
| P2860 | cites work | Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Q24601951 |
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein | Q24652294 | ||
| A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model | Q24654226 | ||
| Statistical significance for genomewide studies | Q24681264 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms | Q28742033 | ||
| Gut Microbiota in Health and Disease | Q29616812 | ||
| Functional interactions between the gut microbiota and host metabolism | Q29616815 | ||
| Bile salt biotransformations by human intestinal bacteria | Q29622858 | ||
| Systemic gut microbial modulation of bile acid metabolism in host tissue compartments | Q30499029 | ||
| Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis | Q30978199 | ||
| The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects | Q33290848 | ||
| Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease | Q42989185 | ||
| RETRACTED: Bacterial lipopolysaccharide-induced oxidative stress in adult rat Sertoli cells in vitro | Q43178006 | ||
| The effects of probiotic and conventional yoghurt on lipid profile in women | Q43184538 | ||
| Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1. | Q43332026 | ||
| Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice. | Q44680789 | ||
| Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. | Q46123291 | ||
| Mechanism of conjugated linoleic acid and vaccenic acid formation in human faecal suspensions and pure cultures of intestinal bacteria. | Q46178001 | ||
| Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease | Q46595049 | ||
| Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal bifidobacterium populations in a prebiotic and probiotic feeding trial | Q48346746 | ||
| Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. | Q51575186 | ||
| Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. | Q54372805 | ||
| Influence of probiotic supplemented infant formula on composition of plasma lipids in atopic infants | Q74379671 | ||
| A cross-study comparison of gene expression studies for the molecular classification of lung cancer | Q80059795 | ||
| Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR | Q83311549 | ||
| Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome | Q84705462 | ||
| Diversity of the human gastrointestinal tract microbiota revisited. | Q33293596 | ||
| Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota | Q33438228 | ||
| Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults | Q33464636 | ||
| Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine | Q33495184 | ||
| Impact of a synbiotic food on the gut microbial ecology and metabolic profiles | Q33522471 | ||
| Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome | Q33525543 | ||
| Functionality of probiotics and intestinal lactobacilli: light in the intestinal tract tunnel | Q33744907 | ||
| Colonization-induced host-gut microbial metabolic interaction | Q33833363 | ||
| Dietary cholesterol: from physiology to cardiovascular risk | Q34026016 | ||
| Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions | Q34141690 | ||
| Cancer gene prioritization by integrative analysis of mRNA expression and DNA copy number data: a comparative review | Q34207183 | ||
| Reanalysis and simulation suggest a phylogenetic microarray does not accurately profile microbial communities | Q34212029 | ||
| The adult intestinal core microbiota is determined by analysis depth and health status. | Q34286453 | ||
| Enrichment or depletion of a GO category within a class of genes: which test? | Q34593379 | ||
| Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults | Q34626824 | ||
| Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria. | Q34633825 | ||
| Effect of antibiotic treatment on the intestinal metabolome | Q34737775 | ||
| High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. | Q34862196 | ||
| Effects of consumption of probiotics and prebiotics on serum lipid levels in humans | Q34865812 | ||
| The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins | Q35829917 | ||
| Probiotic and other functional microbes: from markets to mechanisms | Q36098522 | ||
| The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. | Q36638662 | ||
| Metabolic diversity of the intestinal microbiota: implications for health and disease | Q36740849 | ||
| Nutrition and colonic health: the critical role of the microbiota | Q37016750 | ||
| Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults | Q37240389 | ||
| Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults | Q37267287 | ||
| integrOmics: an R package to unravel relationships between two omics datasets | Q37432352 | ||
| Understanding the role of gut microbiome-host metabolic signal disruption in health and disease | Q37891554 | ||
| Plasmalogens the neglected regulatory and scavenging lipid species | Q37896869 | ||
| Fatty acids and inflammation: the cutting edge between food and pharma. | Q37911577 | ||
| Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials | Q37935305 | ||
| The gut microbiota modulates host energy and lipid metabolism in mice | Q39993460 | ||
| Lipidomics: a new window to biomedical frontiers. | Q40033380 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Lactobacillus rhamnosus | Q1607640 |
| lipid | Q11367 | ||
| P304 | page(s) | e32 | |
| P577 | publication date | 2013-02-26 | |
| P1433 | published in | PeerJ | Q2000010 |
| P1476 | title | Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data | |
| P478 | volume | 1 |
| Q35166491 | 16S gut community of the Cameron County Hispanic Cohort |
| Q46242881 | A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics |
| Q40399407 | A metagenomic study of the preventive effect of Lactobacillus rhamnosus GG on intestinal polyp formation in ApcMin/+ mice |
| Q63457594 | A review of probiotic supplementation in healthy adults: helpful or hype? |
| Q64974006 | A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episode. |
| Q91989750 | A structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: A pilot study |
| Q36012463 | Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials |
| Q55556493 | Analysis of the Gut Microbiome of Rural and Urban Healthy Indians Living in Sea Level and High Altitude Areas. |
| Q36280429 | Assessment of complementary feeding of Canadian infants: effects on microbiome & oxidative stress, a randomized controlled trial. |
| Q64081818 | Associations of Probiotic Fermented Milk (PFM) and Yogurt Consumption with and Components of the Gut Microbiota in Healthy Adults |
| Q36089258 | Biome engineering-2020. |
| Q41647419 | Bovine milk oligosaccharides decrease gut permeability and improve inflammation and microbial dysbiosis in diet-induced obese mice. |
| Q52664920 | Cecal Versus Fecal Microbiota in Ossabaw Swine and Implications for Obesity. |
| Q34162526 | Changes of the human gut microbiome induced by a fermented milk product |
| Q64098989 | Characterization a Novel Butyric Acid-Producing Bacterium Collinsella aerofaciens Subsp. Shenzhenensis Subsp. Nov |
| Q47159080 | Complete Genome Sequence of Collinsella aerofaciens Isolated from the Gut of a Healthy Indian Subject |
| Q35838831 | Design and Investigation of PolyFermS In Vitro Continuous Fermentation Models Inoculated with Immobilized Fecal Microbiota Mimicking the Elderly Colon |
| Q47773664 | Development of a Stable Lung Microbiome in Healthy Neonatal Mice |
| Q92742228 | Dietary supplementation with probiotics regulates gut microbiota structure and function in Nile tilapia exposed to aluminum |
| Q89957877 | Diets naturally rich in polyphenols and/or long-chain n-3 polyunsaturated fatty acids differently affect microbiota composition in high-cardiometabolic-risk individuals |
| Q58592979 | Differential effects of coconut versus soy oil on gut microbiota composition and predicted metabolic function in adult mice |
| Q35796665 | Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children |
| Q92814907 | Effects of Lactobacillus plantarum Q180 on Postprandial Lipid Levels and Intestinal Environment: A Double-Blind, Randomized, Placebo-Controlled, Parallel Trial |
| Q46289521 | Effects of microencapsulated Lactobacillus plantarum LIP-1 on the gut microbiota of hyperlipidaemic rats |
| Q90309229 | Egyptian Mongoose (Herpestes ichneumon) Gut Microbiota: Taxonomical and Functional Differences across Sex and Age Classes |
| Q64086661 | Epizootic ulcerative syndrome causes cutaneous dysbacteriosis in hybrid snakehead () |
| Q92363200 | Establishing What Constitutes a Healthy Human Gut Microbiome: State of the Science, Regulatory Considerations, and Future Directions |
| Q38737986 | Ethnic and diet-related differences in the healthy infant microbiome |
| Q35599613 | Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation |
| Q28551279 | Faecal Metaproteomic Analysis Reveals a Personalized and Stable Functional Microbiome and Limited Effects of a Probiotic Intervention in Adults |
| Q28821039 | Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism |
| Q35601233 | Functional dynamics of the gut microbiome in elderly people during probiotic consumption |
| Q58571195 | Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease |
| Q34139851 | Functional genomics of lactic acid bacteria: from food to health |
| Q36100831 | Gut Microbiota: Modulation of Host Physiology in Obesity |
| Q36271749 | Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke |
| Q46939783 | Gut microbial metabolites of polyunsaturated fatty acids correlate with specific fecal bacteria and serum markers of metabolic syndrome in obese women |
| Q92498449 | Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context |
| Q47176743 | Gut microbiota and body composition in anorexia nervosa inpatients in comparison to athletes, overweight, obese, and normal weight controls. |
| Q35113086 | Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals |
| Q46318762 | Human genetic variation and the gut microbiome in disease |
| Q34980773 | Human gut microbiota changes reveal the progression of glucose intolerance |
| Q60585225 | Hypothesis Testing and Statistical Analysis of Microbiome |
| Q35891840 | Impact of increasing fruit and vegetables and flavonoid intake on the human gut microbiota |
| Q35952315 | Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice |
| Q33551724 | Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study |
| Q41984160 | Insight into the Draft Genome Sequence of Human Isolate Lactobacillus rhamnosus LR231, a Bacterium with Probiotic Potential |
| Q46734774 | Intestinal Microbiota Signatures Associated With Histological Liver Steatosis in Pediatric-Onset Intestinal Failure |
| Q41943716 | Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis |
| Q33851862 | Lactobacillus reuteri I5007 Modulates Intestinal Host Defense Peptide Expression in the Model of IPEC-J2 Cells and Neonatal Piglets |
| Q35998372 | Lactobacillus rhamnosus GG Intake Modifies Preschool Children's Intestinal Microbiota, Alleviates Penicillin-Associated Changes, and Reduces Antibiotic Use. |
| Q39044349 | Mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotics |
| Q55405958 | Metabolic Footprinting of Fermented Milk Consumption in Serum of Healthy Men. |
| Q90481063 | Metabolic Profiling of High Egg Consumption and the Associated Lower Risk of Type 2 Diabetes in Middle-Aged Finnish Men |
| Q90114934 | Metatranscriptomic analysis to define the Secrebiome, and 16S rRNA profiling of the gut microbiome in obesity and metabolic syndrome of Mexican children |
| Q55384385 | Modulation of Active Gut Microbiota by Lactobacillus rhamnosus GG in a Diet Induced Obesity Murine Model. |
| Q33881009 | Molecular ecological network analysis reveals the effects of probiotics and florfenicol on intestinal microbiota homeostasis: An example of sea cucumber |
| Q55373987 | Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model. |
| Q40327612 | Nutrition recommendations and science: next parallel steps |
| Q39429041 | Probiotic pre-administration reduces mortality in a mouse model of cecal ligation and puncture-induced sepsis |
| Q28539546 | Rapid resolution liquid chromatography coupled with quadrupole time-of-flight mass spectrometry-based metabolomics approach to study the effects of jieduquyuziyin prescription on systemic lupus erythematosus |
| Q51278644 | Reduction in cardiometabolic risk factors by a multifunctional diet is mediated via several branches of metabolism as evidenced by nontargeted metabolite profiling approach. |
| Q92163267 | Relationship between gut microbiota and circulating metabolites in population-based cohorts |
| Q38703051 | Relative variations of gut microbiota in disordered cholesterol metabolism caused by high-cholesterol diet and host genetics. |
| Q100385916 | Safety and functional enrichment of gut microbiome in healthy subjects consuming a multi-strain fermented milk product: a randomised controlled trial |
| Q92982886 | The Pacific harbor seal gut microbiota in Mexico: Its relationship with diet and functional inferences |
| Q34340545 | The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model |
| Q34041082 | The first 1000 cultured species of the human gastrointestinal microbiota. |
| Q44401760 | To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes |
| Q36854069 | Unique plasma metabolomic signatures of individuals with inherited disorders of long-chain fatty acid oxidation. |
Search more.